Author + information
- Received October 13, 1989
- Revision received February 13, 1990
- Accepted March 13, 1990
- Published online September 1, 1990.
- Amar Nath, MD, FACC,
- Germano Disciascio, MD, FACC∗,
- Kim M. Kelly, BSN,
- George W. Vetrovec, MD, FACC,
- Chris Testerman, RN,
- Evelyne Goudreau, MD, FRCP(C) and
- Michael J. Cowley, MD, FACC
- ↵∗Address for reprints: Germano DiSciascio, MD, Box 36, Medical College of Virginia Station, Richmond, Virginia 23298.
Coronary angioplasty has been applied in patients with recent myocardial infarction, but results of angioplasty of multiple vessels early after myocardial infarction in patients with severe multivessel disease have not been reported. Coronary angioplasty of multiple vessels was performed in 105 patients 0 to 15 days (mean 5 ± 4) after recent myocardial infarction. There were 77 men (73%) and 28 women (27%), with a mean age of 57 years. All patients had severe multivessel disease, 68% with two vessel and 32% with three vessel disease. Twenty-eight patients (27%) had successful thrombolysis before angioplasty and 70 (67%) had postinfarction angina. Mean left ventricular ejection fraction was 58 ± 10% end was <45% in 13 patients (12%).
Angioplasty was attempted in 319 lesions (mean 3 lesions per patient, range 2 to 9) and 252 vessels (mean 2.4 vessels per patient, range 2 to 4), with success in 302 lesions (95%) and 237 vessels (94%); angioplasty was done in two stages in 59 patients (56%). Clinical success was achieved in 102 patients (97%). Complications included myocardial infarction in six patients (5.7%) (one Q wave, five non-Q wave), urgent bypass surgery in two (1.9%) and death in one (0.9%); overall, seven patients (7%) had a major complication.
All patients had a follow-up duration >1 year (mean 31 months, range 12 to 73). Clinical recurrence developed in 24 patients (23%), of whom 21 had repeat angioplasty, 1 had bypass surgery and 2 were managed medically. Ten patients (9.8%) had a late infarction and 5 (4.9%) died of cardiac death during the follow-up period. Including patients who underwent repeat angioplasty, 88 patients (86%) remain improved (75 asymptomatic, 13 in Canadian Heart Association functional class I) without need of bypass surgery. The actuarial survival rate was 94% at 24 months and the event-free survival rate (no myocardial infarction, death or bypass surgery) was 85% at 2 years.
These initial and long-term results indicate that coronary angioplasty of multiple vessels is a safe and effective therapy in selected patients with severe multivessel disease after recent myocardial infarction.
- Received October 13, 1989.
- Revision received February 13, 1990.
- Accepted March 13, 1990.